Flares can temporarily become more frequent when urate-lowering treatment begins. The NHS says this can happen in the first few months of allopurinol treatment, while NICE notes treat-to-target treatment can increase flares initially but reduce them over longer follow-up.
Flares can temporarily become more frequent when urate-lowering treatment begins. The NHS says this can happen in the first few months of allopurinol treatment, while NICE notes treat-to-target treatment can increase flares initially but reduce them over longer follow-up.
Verdict: Misleading.
Flares can temporarily become more frequent when urate-lowering treatment begins. The NHS says this can happen in the first few months of allopurinol treatment, while NICE notes treat-to-target treatment can increase flares initially but reduce them over longer follow-up.
Read the primary guidance/source →
Evidence reviewed September 2026. Fact checks address the claim, not an individual reader’s diagnosis or treatment.
General educational information, not individual medical advice. Do not start, stop or change prescribed treatment based on this page.